… Shana Godfred-Cato, DO 1 ; Bobbi Bryant, MPH 1 ,2 ; Jessica Leung, MPH 1 ; Matthew E.
Oster, MD 1 ; Laura Conklin, MD 1 ; Joseph Abrams, PhD 1 ; Katherine Roguski, MPH 1 ; …

Importance Multisystem inflammatory syndrome in children (MIS-C) is associated with recent
or current SARS-CoV-2 infection. Information on MIS-C incidence is limited. Objective To …

Importance Multiple inflammatory syndrome in children (MIS-C) occurs in association with
the COVID-19 pandemic. Objective To describe the clinical characteristics and geographic …

Background Multisystem inflammatory syndrome in children (MIS-C) is a newly identified
and serious health condition associated with SARS-CoV-2 infection. Clinical manifestations …

Objective To develop a more comprehensive description of multisystem inflammatory
syndrome in children (MIS-C), a novel syndrome linked to severe acute respiratory syndrome …

Importance Multisystem inflammatory syndrome in adults (MIS-A) has not been well
described. Improved diagnosis and treatment of MIS-A might mitigate COVID-19 morbidity and …

Background Multisystem inflammatory syndrome in children (MIS-C) is a severe
hyperinflammatory condition in persons aged <21 years associated with antecedent severe acute …

Background: Distinguishing multisystem inflammatory syndrome in children (MIS-C) from
coronavirus disease 2019 (COVID-19), Kawasaki disease (KD), and toxic shock syndrome (TSS…

Although mpox is rare among children in the United States, pediatric cases are being
reported during the 2022 multinational mpox outbreak. Vaccines and antiviral medications …

Background: The incidence of multisystem inflammatory syndrome in children (MIS-C) varies
by race and ethnicity. This study assessed whether disparities in MIS-C in the United States …